Kursprognose für Rhythm Pharmaceuticals Inc (RYTM)RYTMRhythm Pharmaceuticals Inc

Alphio's RYTM stock price prediction model matches the current Rhythm Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $91.18 (-0.86%). The 1-week path is $94.63 (+2.89%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Rhythm Pharmaceuticals is currently a hold. The stock is priced at $89.27, with a forward P/E ratio of 526.32, indicating high expectations for future earnings, but it also has a negative net income margin of -69.19%. The recent approval of IMCIVREE in Japan and significant revenue growth of 47% year-over-year in Q2 2026 are positive catalysts. However, the high forward P/E and recent insider selling activity (288.14% increase) suggest caution. The main risk is the high forward P/E ratio, which indicates that the market has high expectations for future performance that may not be met.

Rhythm Pharmaceuticals Inc (RYTM) last closed at $91.9700012, losing -0.23%. These facts feed the 1-day and 1-week RYTM price prediction above.